MedPath

Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy

Completed
Conditions
Epilepsy
Registration Number
NCT00264680
Lead Sponsor
GlaxoSmithKline
Brief Summary

Validation of qolie-10, an epilepsy specific quality of life questionnaire in patients treated with lamotrigine or valproic acid. Comparison of quality of life of epileptic patients treated with lamotrigine or valproic acid. Determination and assessment of the comparative safety of lamotrigine or valproic acid. Assessment and comparison of body image perception in women treated with lamotrigine or valproic acid.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
333
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Validity, feasibility and reliability of qolie-10 (test-retest, internal consistency) 2. Qolie-10 scores between groups 3. Body image scores between groups
Secondary Outcome Measures
NameTimeMethod
Adverse Events: nature and number between groups
© Copyright 2025. All Rights Reserved by MedPath